Skip to main content
  • Statins Make Economic Sense for Borderline-Risk Patients

    Data support giving primary prevention statin therapy to several million more people

    A cost-effectiveness analysis provides economic justification for the 2018 American guideline recommendation to consider statin treatment in certain patients with borderline risk, investigators showed.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details